Journal of the National Cancer Institute Advance Access originally published online on September 11, 2007
JNCI Journal of the National Cancer Institute 2007 99(18):1358-1365; doi:10.1093/jnci/djm165
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
NEWS |
Experts Fear Swedish Snus Sales in the U.S. Could Thwart Anti-Tobacco Measures
| The first 10% of the full text of this article appears below. |
A new product on the market in a handful of U.S. cities has stirred up mixed feelings in the public-health community. Known as snus (rhymes with "goose"), it is a smokeless tobacco product that has been used in Sweden for nearly a century. Because it has lower levels of cancer-causing toxins than cigarettes or other smokeless tobacco products that are currently sold in the U.S. (such as chewing or dipping tobacco) some public-health experts are wondering whether snus could be a less dangerous substitute for smoking.
Within the public-health community, there are two camps on this issue. Most believe that no tobacco product should ever be promoted because even a "safer" product is still not safe. But the other side, an outspoken minority, thinks it is better to